Quantcast

Latest COPD Stories

2014-09-09 08:31:47

LONDON, ON, Sept. 9, 2014 /PRNewswire/ - New study results presented today at the European Respiratory Society (ERS) Conference in Munich Germany provide further evidence that the Aerobika* OPEP device developed by Trudell Medical International (TMI) provides an important treatment for the 250 million patients suffering from COPD globally. Many of these patients suffer from excessive mucus resulting in breathlessness, the inability to do everyday activities, and decreased quality of...

2014-09-08 16:24:59

WWII Veteran Bob Scott to Tour Washington, D.C. Memorials Using the Breathe NIOV System IRVINE, Calif., Sept. 8, 2014 /PRNewswire/ -- Breathe Technologies, a developer and manufacturer of innovative medical technologies for patients with respiratory insufficiency diseases and neuromuscular diseases, will sponsor World War II Veteran and Colton, Calif. resident Bob Scott on a September trip to Washington, D.C., as part of the Honor Flight Network. The Breathe Non-Invasive Open...

2014-09-08 12:30:18

Additionally, data from the WISDOM trial on stepwise withdrawal of ICS in COPD was also presented at ERS and simultaneously published in the New England Journal of Medicine RIDGEFIELD, Conn., Sept. 8, 2014 /PRNewswire/ -- Boehringer Ingelheim today presented the first data from the pivotal Phase III TONADO(TM) 1&2 studies (NCT01431274/NCT01431287) for the fixed-dose combination (FDC) of tiotropium plus olodaterol delivered via the Respimat(®) inhaler in patients with moderate to...

2014-09-08 08:29:55

-- LANTERN study met primary endpoint demonstrating non-inferiority of Ultibro® Breezhaler® 110/50 mcg vs Advair* Diskus* (SFC) 50/500 mcg followed by statistically significant superiority in post dose trough FEV1 after 26 weeks of treatment in patients with moderate-to-severe COPD1 -- In addition, LANTERN study met an endpoint demonstrating that Ultibro®Breezhaler ® reduced...

2014-09-04 23:03:46

MedicationDiscountCard.com offers Veramyst discount cards, along with discount cards for other similar medications. These discount cards can save patients 10-75% on prescription drugs that treat or help manage COPD. Margate City, NJ (PRWEB) September 04, 2014 Recent reports from the Centers for Disease Control indicate that nearly 7% of the US population is currently dealing with chronic obstructive pulmonary disease, or COPD (cdc.gov/Features/copdadults/). It may also be called COLD...

2014-08-21 12:29:36

Despite Cost and Coverage Constraints, Physicians Manage to Prescribe LABA and LAMA Regimens in Combination for COPD, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug. 21, 2014 /PRNewswire/ -- Decision Resources Group finds that, for the treatment of COPD, physicians in Brazil and Mexico manage to follow clinical guidelines and commonly prescribe long-acting beta-agonist (LABA)- and long-acting muscarinic antagonist (LAMA)- containing regimens, although they do so...

2014-08-19 12:28:32

For U.S. Media Only RIDGEFIELD, Conn., Aug. 19, 2014 /PRNewswire/ -- Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) accepted for review the New Drug Application (NDA) for the fixed-dose combination (FDC) of tiotropium and olodaterol delivered via the Respimat(®) inhaler for the proposed indication of long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including...

2014-08-14 16:27:26

Committee Voted Based on Clinical Data from Eight Efficacy Trials RIDGEFIELD, Conn., Aug. 14, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) voted [10 yes, 3 no] that existing data supports approval of Boehringer Ingelheim's investigational tiotropium bromide inhalation spray for long-term, once-daily maintenance treatment of bronchospasm associated...

2014-08-05 08:35:30

New site is filled with information, patient testimonials, easy-to-use tools and real-world tips for people affected by COPD RESEARCH TRIANGLE PARK, N.C., Aug. 5, 2014 /PRNewswire/ -- Today GlaxoSmithKline plc (LSE/NYSE: GSK) announced the launch of the redesigned COPD.com website, which provides disease education, interactive tools, tips and inspirational testimonials from patients living with chronic obstructive pulmonary disease (COPD), for an up-close and personal look at managing and...

2014-08-04 08:27:41

New Study Published in The Lancet Respiratory Medicine is First to Provide Strong Evidence Supporting Long-term NPPV in the Treatment of COPD SAN DIEGO, Aug. 4, 2014 /PRNewswire/ -- Long-term non-invasive positive pressure ventilation (NPPV) - also known as non-invasive ventilation -- significantly improved long-term survival, exercise capacity, and health-related quality of life when added to current guidelines for the treatment of patients with advanced-stage chronic obstructive...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'